awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33391725-A5DA0BEB-12AB-4BD4-9964-F49C2149AD01
Q33391725-A5DA0BEB-12AB-4BD4-9964-F49C2149AD01
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33391725-A5DA0BEB-12AB-4BD4-9964-F49C2149AD01
Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG).
P2860
Q33391725-A5DA0BEB-12AB-4BD4-9964-F49C2149AD01
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33391725-A5DA0BEB-12AB-4BD4-9964-F49C2149AD01
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
157a27f8e5c0a16c96b99f14c8d8130ed9c803c2
P2860
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.